10x Genomics rises on Q4 earnings beat Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates 10x Genomics (TXG) delivered earnings and revenue surprises of 48.28% and 6.50%, respectively, for the quarter ended December 2022. Do…
Insights on the Single Cell Genomics Global Market to 2027: Players Include 10x Genomics, 1CellBio, Agilent/Dako and Beckman Coulter Diagnostics DUBLIN , Jan. 20, 2023 /PRNewswire/ -- The "Single Cell Genomics Markets. Forecasts by Technology, Product, Workflow, User and Country…
10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023 PLEASANTON, Calif., Jan. 19, 2023 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the…
3 Medical Info Systems Stocks Braving Industry-wide Headwinds Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to…
Human Gene Sequencing Market Report 2023: Featuring 10x Genomics, Abbott Diagnostics, Eurofins Scientific, GE Global Research & More DUBLIN, Jan. 5, 2023 /PRNewswire/ -- The "Human Gene Sequencing Markets, Strategies & Trends - Forecasts by Application, by Technology,…
10x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference PLEASANTON, Calif., Dec. 28, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology…
Spatial Genomics, Transcriptomics and Proteomics Solutions Market Report 2022: Featuring 10x Genomics, Lunaphore Technologies, Canopy Biosciences & More DUBLIN, Dec. 22, 2022 /PRNewswire/ -- The "Spatial Genomics, Transcriptomics and Proteomics Solutions Market - Distribution by Type of Solution,…
10x Genomics Commercially Launches Xenium Platform for In Situ Analysis Began global shipments of Xenium Analyzer, the highest throughput instrument for subcellular In Situ profiling PLEASANTON, Calif., Dec. 8, 2022…
10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discovery Barcode Enabled Antigen Mapping (BEAM) screens multiple antigens against thousands of B- or T-cells to identify novel and rare antigen-specific…
Form 10-Q 10x Genomics, Inc. For: Sep 30 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates 10x Genomics (TXG) delivered earnings and revenue surprises of 17.78% and 1.32%, respectively, for the quarter ended September 2022. Do…
10x Genomics GAAP EPS of -$0.37 beats by $0.11, revenue of $131.07M beats by $1.94M Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Will 10x Genomics Disappoint Investors Again? Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
10x Genomics to Host Investor Day on December 8, 2022 PLEASANTON, Calif., Oct. 31, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will host an Investor Day on…
10x Genomics to Report Third Quarter Financial Results on November 2, 2022 PLEASANTON, Calif., Oct. 12, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the…